What was BioNTech SE's revenue in 2023?

BioNTech SE reported $4.2B in revenue for fiscal year 2023. This represents a -78.0% change compared to 2022. Revenue collapsed roughly 78.0 percent from the prior year as COVID-19 vaccine demand fell sharply and the virus shifted toward endemic status.

How did BioNTech SE's revenue change from 2022 to 2023?

BioNTech SE revenue declined from $18.9B in 2022 to $4.2B in 2023, a change of -78.0%.

Was 2023 BioNTech SE's best revenue year?

No. BioNTech SE's highest recorded revenue year was 2022 at $18.9B. In 2023, BioNTech SE reported $4.2B.

What was BioNTech SE's highest ever annual revenue?

BioNTech SE's highest ever annual revenue was $18.9B recorded in fiscal year 2022.

BioNTech SE

Biotechnology / ImmunotherapyFounded 2008

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.

Annual Revenue

BioNTech SE Revenue in 2023

FY2023 Revenue

$4.2B

▼ 78% vs FY2022 ($18.9B)

Source: Annual report / company filing

BioNTech SE reported $4.2B in revenue for fiscal year 2023. This represents a decline of 78% compared to the 2022 figure of $18.9B. In 2024, revenue declined to $3.0B.

Revenue collapsed roughly 78.0 percent from the prior year as COVID-19 vaccine demand fell sharply and the virus shifted toward endemic status.

Revenue by Year

FY2025 FY2024 FY2023 FY2022

BioNTech SE Annual Revenue History

Year	Revenue	YoY Change
FY2025	$3.2B	+5.7%
FY2024	$3.0B	-27.9%
FY2023	$4.2B	-78.0%
FY2022	$18.9B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2022: $18.9B

Next year →

FY2024: $3.0B

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.